In this study, we investigate how M. restricta affects healthy skin, AD lesions, and AD lesions undergoing treatment with ruxolitinib or anti-IL4Rα in 3D RHE with respect to skin barrier function and inflammation. The gene discussed is IL4R; the disease is Alzheimer disease.